US 10555929
Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy
granted A61KA61K31/355A61K31/4709
Quick answer
US patent 10555929 (Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy) held by Coherus BioSciences, Inc. expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Coherus BioSciences, Inc.
- Grant date
- Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/355, A61K31/4709, A61P, A61P1/16